Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 7 results for "nirmal bang"

Nirmal Bang bullish on Indian food sector

In an interview with CNBC-TV18, Rahul Arora, CEO of Nirmal Bang Institutional Equities, spoke about his reading and perspective on Indian food sector. Money Control, 4 days ago

9 images for nirmal bang

Money Control, 2 weeks ago
Money Control, 2 months ago
Money Control, 2 months ago
Money Control, 4 months ago
Money Control, 5 months ago
Money Control, 6 months ago
Money Control, 8 months ago
Money Control, 7 months ago
Money Control, 8 months ago
Money Control

Hold Minda Industries; target of Rs 1175: Nirmal Bang

Nirmal Bang is bullish on Minda Industries has recommended hold rating on the stock with a target price of Rs 1175 in its research report dated February 20, 2018.
 Money Control2 weeks ago Buy Shemaroo Entertainment; target of Rs 612: Nirmal Bang  Money Control2 months ago Buy S Chand and Company Ltd; target of Rs 632: Nirmal Bang  Money Control2 months ago

Here#39;s a fundamental view on market from Girish Pai

Watch the interview of Girish Pai, Head Of Research at Nirmal Bang with Prashant Nair and Ekta Batra on CNBC-TV18, in which he shared his readings and outlook on FY19 earnings.
 Money Control2 weeks ago

Here are Kunal Shah#39;s commodity trading ideas

Watch the interview of Kunal Shah, Head of Commodities Currency Research at Nirmal Bang Commodities with Manisha Gupta on CNBC-TV18. He spoke about the current trend in commodities market.
 Money Control2 months ago

Aurbindo Pharma ranks 2nd among Indian's pharma cos

With sales of over Rs 12,240 crore in nine months of the current financial year, it is ahead of Rs 11,580 crore recorded by Lupin but behind Sun Pharma, which reported Rs 19,350 crore sales. P V Ramaprasad Reddy, co-founder of Aurbindo Pharma, is known for his ability to learn along the way.   Some years ago he moved to the US to build business in new segments such as injectables, controlled substance and nutraceuticals. This has now helped the firm move up the value chain in formulations ...
 Rediff.com4 weeks ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less